T1和T2期胆囊癌外科治疗研究进展  

Progress in the surgical treatment of T1 and T2stage gallbladder cancers

作　　者：张锐[1] 赵舸[2] Zhang Rui;Zhao Ge(Shanxi Medical University,Taiyuan 030001,China;Department of General Surgery,the Second Hospital of Shanxi Medical University,Taiyuan 030001,China)

机构地区：[1]山西医科大学,太原030001 [2]山西医科大学第二医院普通外科,太原030001

出　　处：《中华普通外科学文献（电子版）》2024年第3期225-228,共4页Chinese Archives of General Surgery(Electronic Edition)

摘　　要：T1、T2期胆囊癌处于局部早中期,手术切除是首选治疗方法,通过制定合理的手术方案,多数患者预后良好。目前,国内外在Tis及T1a期胆囊癌治疗上已达成共识,但T1b、T2a、T2b期胆囊癌的治疗策略仍存在许多争议,尤其是在肝脏切除和淋巴结清扫范围上没有明确的共识。因此,外科医师应针对不同的患者,需要充分评估和预测,制定适合患者的最佳治疗方案,以获得更好的预后。T1-and T2-stage gallbladder cancer belongs to early and middle stage,and surgical resection is the first choice of treatment.By formulating reasonable surgical methods,most patients have good prognosis.At present,there is consensus on the treatment of Tis and T1a patients at home and abroad,but there are still many disputes on the treatment strategy of T1b,T2a and T2b patients,especially on the scope of hepatectomy and lymph node dissection.Therefore,surgeons need to fully evaluate,predict,and formulate the optimal treatment plans for different patients to achieve better prognosis.

关 键 词：胆囊肿瘤 TNM分期 淋巴转移 肝切除术 

分 类 号：R73[医药卫生—肿瘤]